Clinical Trials Directory

Trials / Completed

CompletedNCT00842985

Dronabinol Interactions With Cognitive Enhancing Drug in Humans

Dronabinol Interactions in Humans

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
53 (actual)
Sponsor
Yale University · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Not accepted

Summary

Marijuana use is a major problem among veterans and non-veterans. A patient's use of marijuana while engaged in psychotherapy treatment may affect their memory and, therefore, limit their ability to benefit from treatment. This study is designed to test a new pharmacotherapy, modafinil, which has the potential to improve memory functioning in marijuana using individuals. We hypothesize that modafinil treatment will decrease ratings of drug liking and improve cognitive measures, especially episodic memory.

Detailed description

The impairment of episodic memory in marijuana abusers has important treatment implications. Since many treatments, including cognitive-behavioral therapy, strongly utilize episodic memory, marijuana use during treatment may lead to diminished treatment outcomes. In addition, lessened response inhibition may lead to elevated rates of drug relapse while in treatment. Consequently, a treatment which will improve episodic memory and response inhibition may lead to improved treatment outcomes in marijuana users. One such treatment is modafinil.This study will be a 4 session within-subjects, double-blind, crossover study evaluating the impact of modafinil (400 mg/day) on the cognitive, subjective, and physiological effects of marijuana. Across 4 sessions, subjects will be randomly assigned to receive either oral placebo, modafinil (400mg), dronabinol (15mg), or dronabinol and modafinil. Outcome measures will include physiological, cognitive, and subjective drug effects. Currently this study complete and has been published.

Conditions

Interventions

TypeNameDescription
DRUGdrug conditionDronabinol (15mg) or Modafinil (400mg) or Dronabinol + Modafanil or placebo

Timeline

Start date
2008-09-01
Primary completion
2009-10-01
Completion
2009-10-01
First posted
2009-02-12
Last updated
2017-05-30
Results posted
2012-12-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00842985. Inclusion in this directory is not an endorsement.